References - Therapeutic Strategies in Cancer Biology and Pathology - page 195

promoter region in gastric intestinal metaplasia and cancer cells. Am. J. Pathol. 163,
1911-1919.
Akutagawa, A., Fukami, K., Banno, Y., Takenawa, T., Kannagi, R., Yokoyama, Y., et al., 2006.
Disruption of phospholipase C delta 4 gene modulates the liver regeneration in coopera-
tion with nuclear protein kinase C. J. Biochem. 140, 619-625.
Al-Alwan, M., Olabi, S., Ghebeh, H., Barhoush, E., Tulbah, A., Al-Tweigeri, T., et al., 2011.
Fascin is a key regulator of breast cancer invasion that acts via the modification of metas-
tasis-associated molecules. PLoS ONE 6, e27339.
Al-Hajj, M., Wicha, S.M., Benito-Hernandez, A., Morrison, S.J., Clarke, M.F., 2003.
Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci.
U.S.A. 100, 3983-3988.
Alimova, I.N., Liu, B., Fan, Z., Edgerton, S.M., Dillon, T., Lind, S.E., et al., 2009. Metformin
inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro.
Cell Cycle 8, 909-915.
Al-Mulla, F., Hagan, S., Al-Ali, W., Jacob, S.P., Behbehani, A.I., Bitar, M.S., et al., 2008. Raf
kinase inhibitor protein: mechanism of loss of expression and association with genomic
instability. J. Clin. Pathol. 61, 524-529.
Al-Mulla, F., Bitar, M.S., Taqi, Z., Rath, O., Kolch, W., 2011. RAF kinase inhibitory protein
(RKIP) modulates cell cycle kinetics and motility. Mol. Biosyst. 7, 928-941.
Alvarez, C.E., 2008. On the origins of arrestin and rhodopsin. BMC Evol. Biol. 8, 222.
Ambros, V., Lee, R.C., Lavanway, A., Williams, P.T., Jewell, D., 2003. MicroRNAs and other
tiny endogenous RNAs in C. elegans. Curr. Biol. 13, 807-818.
Ananthanarayanan, B., Das, S., Rhee, S.G., Murray, D., Cho, W., 2002. Membrane targeting
of C2 domains of phospholipase C-delta isoforms. J. Biol. Chem. 277, 3568-3575.
Andersen, K., Nesland, J.M., Holm, R., Florenes, V.A., Fodstad, O., Maelandsmo, G.M.,
2004. Expression of S100A4 combined with reduced E-cadherin expression predicts
patient outcome in malignant melanoma. Mod. Pathol. 17, 990-997.
Andersen, S.D., Keijzers, G., Rampakakis, E., Engels, K., Luhn, P., El-Shemerly, M., et al.,
2012. 14-3-3 checkpoint regulatory proteins interact specifically with DNA repair protein
human exonuclease 1 (hEXO1) via a semi-conserved motif. DNA Repair 11, 267-277.
Ang, E.S.M., Pavlos, N.J., Chai, L.Y., Qi, M., Cheng, T.S., Steer, J.H., et al., 2009. Caffeic
acid phenethyl ester, an active component of honeybee Propolis attenuates osteoclas-
togenesis and bone resorption via the suppression of RANKL-induced NF-kappa B and
NFAT ctivity. J. Cell. Physiol. 221, 642-649.
Angeles, C., Moreno-Bueno, G., Romero-Perez, L., Van De Vijver, K., Biscuola, M., Angeles,
L.G.M., et al., 2011. Micro-RNA signature of the epithelial-mesenchymal transition in
endometrial carcinosarcoma. J. Pathol. 223, 72-80.
Angus, L., Moleirinho, S., Herron, L., Sinha, A., Zhang, X., Niestrata, M., et al., 2012. Willin/
FRMD6 expression activates the Hippo signaling pathway kinases in mammals and
antagonizes oncogenic YAP. Oncogene 31, 238-250.
Antognelli, C., Del Buono, C., Ludovini, V., Gori, S., Talesa, V.N., Crino, L., et al., 2009.
CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer:
an Italian case-control study. BMC Cancer 9, 115.
Aprelikova, O., Pace, A.J., Fang, B., Koller, B.H., Liu, E.T., 2001. BRCA1 is a selective co-
activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. J. Biol.
Chem. 276, 25647-25650.
Apte, U., Zeng, G., Muller, P., Tan, X., Micsenyi, A., Cieply, B., et al., 2006. Activation of
Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in
mice. Hepatology 44, 992-1002.